pharyngolaryngeal


Also found in: Dictionary.

pha·ryn·go·la·ryn·ge·al

(fă-ring'gō-lă-rin'jē-ăl), Avoid the mispronunciation pharyngolarynge'al.
Relating to both the pharynx and the larynx.

pha·ryn·go·la·ryn·ge·al

(fă-ring'gō-lă-rin'jē-ăl)
Relating to both the pharynx and the larynx.

pharyngolaryngeal

(fă-rĭng″gō-lă-rĭn′jē-ăl) [″ + larynx, larynx]
Concerning the pharynx and larynx.
References in periodicals archive ?
1) We encountered 5 rare cases of pharyngolaryngeal edema with dyspnea associated with mumps infection.
2]O for the entire duration of the procedure to minimise the risk of pharyngolaryngeal adverse events.
While cautioning that a great deal more needs to be learned about pharyngolaryngeal transplants, such as how chronic rejection will express itself in the larynx, the editorialist said the proposed indications for such transplants are reasonable.
Dermatologic Effects of Smokeless Tobacco Direct Effects Indirect Effects Localized gingival recession Oral carcinoma Increased dental caries Esophageal carcinoma Halitosis Pharyngolaryngeal carcinomas Tooth discoloration Gastric carcinoma Tooth abrasions Oral leukoplakia
Treatment-emergent adverse events reported by at least 50% of patients included arthralgia, back pain, pyrexia, upper abdominal pain, pharyngolaryngeal pain and headache.
Adverse reactions: The most frequent adverse reactions observed include headache, nasopharyngitis, sinusitis, pharyngolaryngeal pain, upper respiratory infections, arthralgia, nasal congestion, and pain in extremities or back.
Special Considerations: Bitter taste, headache, epistaxis, pharyngolaryngeal pain, and postnasal drip were adverse events reported in clinical trials that occurred more frequently among those treated with Patanase nasal spray vs.
The most common adverse reactions (rate greater than or equal to 1%) were headache, pharyngolaryngeal pain, throat irritation, nausea, cough, rhinorrhea, dyspnea, chest discomfort, wheezing, retching and dizziness.
Adverse reactions: The most common side effects associated with therapy include headache, diarrhea, abdominal pain, upper respiratory tract infection, pharyngolaryngeal pain, vomiting, and nausea.
Most common adverse events (>/=5%) in the GLOBE trial, regardless of attributability to telbivudine, were upper respiratory tract infection (14%), fatigue and malaise (12%), abdominal pain (12%), nasopharyngitis (11%), headache (11%), blood CPK increased (9%), cough (7%), nausea and vomiting (7%), influenza and influenza-like symptoms (7%), post-procedural pain (7%), diarrhea and loose stools (7%), and pharyngolaryngeal pain (5%).
15-17) The technique has also been applied to free jejunal pharyngolaryngeal reconstruction, and it offers significant advantages in terms of low anastomoses, which would be difficult if not impossible to achieve with a standard hand-sewn anastomosis.